9min read
Peptide Guide
A potent growth-hormone-releasing peptide acting at GHS-R1a and the cardiac receptor CD36, studied for GH release and cardioprotection.
9min read
Peptide Guide
A tripeptide derived from α-MSH studied for anti-inflammatory effects in IBD research, skin inflammation, and broader inflammatory pathway modulation.
8min read
Industry News
Survodutide’s Phase 3 SYNCHRONIZE-1 trial showed 16.6% weight loss at 76 weeks — the third major Phase 3 obesity readout at ADA 2026, NEJM published.
8min read
Industry News
Post-conference summary of the ADA 86th Scientific Sessions outcomes — Phase 3 results for retatrutide, CagriSema, survodutide, and orforglipron.
10min read
Peptide Guide
A standardized porcine brain-derived peptide complex studied for neurotrophic activity, stroke recovery, Alzheimer’s disease, and broader neurological research.
10min read
Peptide Guide
A synthetic α-MSH analog studied for central melanocortin receptor activation and sexual function research applications. FDA-approved for HSDD as Vyleesi.
9min read
Comparison
Semaglutide vs Retatrutide compared head-to-head — single GLP-1 agonist mechanism vs triple-receptor co-activation, regulatory status, and research applications
9min read
Peptide Guide
A 16-amino-acid synthetic fragment of human growth hormone studied for lipolysis, fat metabolism, body composition, and osteoarthritis research applications.
9min read
Peptide Guide
A 16-amino-acid mitochondrial-derived peptide studied for AMPK activation, insulin sensitization, exercise mimetic effects, and metabolic aging research.